nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketorolac—PTGS2—Cisplatin—peripheral nervous system neoplasm	0.162	0.356	CbGbCtD
Ketorolac—PTGS2—Etoposide—peripheral nervous system neoplasm	0.159	0.349	CbGbCtD
Ketorolac—PTGS1—Etoposide—peripheral nervous system neoplasm	0.134	0.295	CbGbCtD
Ketorolac—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000305	CcSEcCtD
Ketorolac—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000166	0.000305	CcSEcCtD
Ketorolac—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000166	0.000304	CcSEcCtD
Ketorolac—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000303	CcSEcCtD
Ketorolac—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000302	CcSEcCtD
Ketorolac—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000164	0.000301	CcSEcCtD
Ketorolac—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000164	0.000301	CcSEcCtD
Ketorolac—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000299	CcSEcCtD
Ketorolac—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000163	0.000299	CcSEcCtD
Ketorolac—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000163	0.000298	CcSEcCtD
Ketorolac—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000297	CcSEcCtD
Ketorolac—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000296	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000161	0.000296	CcSEcCtD
Ketorolac—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000161	0.000296	CcSEcCtD
Ketorolac—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000161	0.000296	CcSEcCtD
Ketorolac—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000294	CcSEcCtD
Ketorolac—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000294	CcSEcCtD
Ketorolac—Pain—Etoposide—peripheral nervous system neoplasm	0.00016	0.000293	CcSEcCtD
Ketorolac—Constipation—Etoposide—peripheral nervous system neoplasm	0.00016	0.000293	CcSEcCtD
Ketorolac—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000293	CcSEcCtD
Ketorolac—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000293	CcSEcCtD
Ketorolac—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000158	0.000291	CcSEcCtD
Ketorolac—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000158	0.00029	CcSEcCtD
Ketorolac—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000289	CcSEcCtD
Ketorolac—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000289	CcSEcCtD
Ketorolac—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000288	CcSEcCtD
Ketorolac—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000286	CcSEcCtD
Ketorolac—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000285	CcSEcCtD
Ketorolac—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000285	CcSEcCtD
Ketorolac—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000284	CcSEcCtD
Ketorolac—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000154	0.000283	CcSEcCtD
Ketorolac—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000282	CcSEcCtD
Ketorolac—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000154	0.000282	CcSEcCtD
Ketorolac—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000281	CcSEcCtD
Ketorolac—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000281	CcSEcCtD
Ketorolac—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000153	0.000281	CcSEcCtD
Ketorolac—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000153	0.00028	CcSEcCtD
Ketorolac—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000152	0.000279	CcSEcCtD
Ketorolac—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000279	CcSEcCtD
Ketorolac—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000151	0.000277	CcSEcCtD
Ketorolac—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000151	0.000277	CcSEcCtD
Ketorolac—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000277	CcSEcCtD
Ketorolac—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00015	0.000276	CcSEcCtD
Ketorolac—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000276	CcSEcCtD
Ketorolac—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00015	0.000275	CcSEcCtD
Ketorolac—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000274	CcSEcCtD
Ketorolac—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000149	0.000273	CcSEcCtD
Ketorolac—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000272	CcSEcCtD
Ketorolac—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000272	CcSEcCtD
Ketorolac—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000272	CcSEcCtD
Ketorolac—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000271	CcSEcCtD
Ketorolac—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000148	0.000271	CcSEcCtD
Ketorolac—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000148	0.000271	CcSEcCtD
Ketorolac—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000271	CcSEcCtD
Ketorolac—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000271	CcSEcCtD
Ketorolac—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000271	CcSEcCtD
Ketorolac—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000147	0.000269	CcSEcCtD
Ketorolac—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000146	0.000269	CcSEcCtD
Ketorolac—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000268	CcSEcCtD
Ketorolac—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000267	CcSEcCtD
Ketorolac—Rash—Vincristine—peripheral nervous system neoplasm	0.000146	0.000267	CcSEcCtD
Ketorolac—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000145	0.000267	CcSEcCtD
Ketorolac—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000266	CcSEcCtD
Ketorolac—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000266	CcSEcCtD
Ketorolac—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000265	CcSEcCtD
Ketorolac—Headache—Vincristine—peripheral nervous system neoplasm	0.000145	0.000265	CcSEcCtD
Ketorolac—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000264	CcSEcCtD
Ketorolac—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000263	CcSEcCtD
Ketorolac—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000142	0.000261	CcSEcCtD
Ketorolac—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000261	CcSEcCtD
Ketorolac—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.00026	CcSEcCtD
Ketorolac—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00014	0.000256	CcSEcCtD
Ketorolac—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000256	CcSEcCtD
Ketorolac—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000255	CcSEcCtD
Ketorolac—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000253	CcSEcCtD
Ketorolac—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000138	0.000253	CcSEcCtD
Ketorolac—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000252	CcSEcCtD
Ketorolac—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000252	CcSEcCtD
Ketorolac—Nausea—Vincristine—peripheral nervous system neoplasm	0.000137	0.000252	CcSEcCtD
Ketorolac—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000251	CcSEcCtD
Ketorolac—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000251	CcSEcCtD
Ketorolac—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000251	CcSEcCtD
Ketorolac—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.00025	CcSEcCtD
Ketorolac—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.00025	CcSEcCtD
Ketorolac—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000247	CcSEcCtD
Ketorolac—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000134	0.000246	CcSEcCtD
Ketorolac—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000246	CcSEcCtD
Ketorolac—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000246	CcSEcCtD
Ketorolac—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000246	CcSEcCtD
Ketorolac—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000245	CcSEcCtD
Ketorolac—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000244	CcSEcCtD
Ketorolac—Chills—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000243	CcSEcCtD
Ketorolac—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000132	0.000243	CcSEcCtD
Ketorolac—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000242	CcSEcCtD
Ketorolac—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000241	CcSEcCtD
Ketorolac—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000239	CcSEcCtD
Ketorolac—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00013	0.000238	CcSEcCtD
Ketorolac—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000237	CcSEcCtD
Ketorolac—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000237	CcSEcCtD
Ketorolac—Rash—Cisplatin—peripheral nervous system neoplasm	0.000129	0.000236	CcSEcCtD
Ketorolac—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000129	0.000236	CcSEcCtD
Ketorolac—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000236	CcSEcCtD
Ketorolac—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000236	CcSEcCtD
Ketorolac—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000128	0.000235	CcSEcCtD
Ketorolac—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000234	CcSEcCtD
Ketorolac—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000234	CcSEcCtD
Ketorolac—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000232	CcSEcCtD
Ketorolac—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000232	CcSEcCtD
Ketorolac—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000232	CcSEcCtD
Ketorolac—Tension—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000231	CcSEcCtD
Ketorolac—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000231	CcSEcCtD
Ketorolac—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000229	CcSEcCtD
Ketorolac—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000228	CcSEcCtD
Ketorolac—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000227	CcSEcCtD
Ketorolac—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000124	0.000227	CcSEcCtD
Ketorolac—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000226	CcSEcCtD
Ketorolac—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000226	CcSEcCtD
Ketorolac—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000225	CcSEcCtD
Ketorolac—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000224	CcSEcCtD
Ketorolac—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000121	0.000222	CcSEcCtD
Ketorolac—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000222	CcSEcCtD
Ketorolac—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000221	CcSEcCtD
Ketorolac—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000219	CcSEcCtD
Ketorolac—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000219	CcSEcCtD
Ketorolac—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000119	0.000218	CcSEcCtD
Ketorolac—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000218	CcSEcCtD
Ketorolac—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000218	CcSEcCtD
Ketorolac—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000218	CcSEcCtD
Ketorolac—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000217	CcSEcCtD
Ketorolac—Rash—Etoposide—peripheral nervous system neoplasm	0.000118	0.000216	CcSEcCtD
Ketorolac—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000118	0.000216	CcSEcCtD
Ketorolac—Headache—Etoposide—peripheral nervous system neoplasm	0.000117	0.000215	CcSEcCtD
Ketorolac—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000215	CcSEcCtD
Ketorolac—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000214	CcSEcCtD
Ketorolac—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000214	CcSEcCtD
Ketorolac—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000213	CcSEcCtD
Ketorolac—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000212	CcSEcCtD
Ketorolac—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000212	CcSEcCtD
Ketorolac—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000211	CcSEcCtD
Ketorolac—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000211	CcSEcCtD
Ketorolac—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000211	CcSEcCtD
Ketorolac—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000208	CcSEcCtD
Ketorolac—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000207	CcSEcCtD
Ketorolac—Cough—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000206	CcSEcCtD
Ketorolac—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000206	CcSEcCtD
Ketorolac—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000204	CcSEcCtD
Ketorolac—Nausea—Etoposide—peripheral nervous system neoplasm	0.000111	0.000204	CcSEcCtD
Ketorolac—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000203	CcSEcCtD
Ketorolac—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000202	CcSEcCtD
Ketorolac—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000202	CcSEcCtD
Ketorolac—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000201	CcSEcCtD
Ketorolac—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000201	CcSEcCtD
Ketorolac—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000201	CcSEcCtD
Ketorolac—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.0002	CcSEcCtD
Ketorolac—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000109	0.0002	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000199	CcSEcCtD
Ketorolac—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000198	CcSEcCtD
Ketorolac—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000197	CcSEcCtD
Ketorolac—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000196	CcSEcCtD
Ketorolac—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000196	CcSEcCtD
Ketorolac—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000196	CcSEcCtD
Ketorolac—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000195	CcSEcCtD
Ketorolac—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000194	CcSEcCtD
Ketorolac—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000193	CcSEcCtD
Ketorolac—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000192	CcSEcCtD
Ketorolac—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000192	CcSEcCtD
Ketorolac—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000192	CcSEcCtD
Ketorolac—Infection—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000191	CcSEcCtD
Ketorolac—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.00019	CcSEcCtD
Ketorolac—Shock—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000189	CcSEcCtD
Ketorolac—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000189	CcSEcCtD
Ketorolac—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000189	CcSEcCtD
Ketorolac—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000188	CcSEcCtD
Ketorolac—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000188	CcSEcCtD
Ketorolac—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000188	CcSEcCtD
Ketorolac—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000187	CcSEcCtD
Ketorolac—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000186	CcSEcCtD
Ketorolac—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000186	CcSEcCtD
Ketorolac—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000186	CcSEcCtD
Ketorolac—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000186	CcSEcCtD
Ketorolac—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000185	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000184	CcSEcCtD
Ketorolac—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000183	CcSEcCtD
Ketorolac—Anorexia—Epirubicin—peripheral nervous system neoplasm	9.99e-05	0.000183	CcSEcCtD
Ketorolac—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	9.9e-05	0.000182	CcSEcCtD
Ketorolac—Hypotension—Epirubicin—peripheral nervous system neoplasm	9.8e-05	0.00018	CcSEcCtD
Ketorolac—Confusional state—Doxorubicin—peripheral nervous system neoplasm	9.78e-05	0.000179	CcSEcCtD
Ketorolac—Oedema—Doxorubicin—peripheral nervous system neoplasm	9.7e-05	0.000178	CcSEcCtD
Ketorolac—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	9.7e-05	0.000178	CcSEcCtD
Ketorolac—Infection—Doxorubicin—peripheral nervous system neoplasm	9.64e-05	0.000177	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	9.55e-05	0.000175	CcSEcCtD
Ketorolac—Shock—Doxorubicin—peripheral nervous system neoplasm	9.54e-05	0.000175	CcSEcCtD
Ketorolac—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	9.51e-05	0.000175	CcSEcCtD
Ketorolac—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	9.5e-05	0.000174	CcSEcCtD
Ketorolac—Insomnia—Epirubicin—peripheral nervous system neoplasm	9.48e-05	0.000174	CcSEcCtD
Ketorolac—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	9.47e-05	0.000174	CcSEcCtD
Ketorolac—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	9.42e-05	0.000173	CcSEcCtD
Ketorolac—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	9.41e-05	0.000173	CcSEcCtD
Ketorolac—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	9.38e-05	0.000172	CcSEcCtD
Ketorolac—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	9.35e-05	0.000171	CcSEcCtD
Ketorolac—Somnolence—Epirubicin—peripheral nervous system neoplasm	9.32e-05	0.000171	CcSEcCtD
Ketorolac—Anorexia—Doxorubicin—peripheral nervous system neoplasm	9.25e-05	0.00017	CcSEcCtD
Ketorolac—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	9.23e-05	0.000169	CcSEcCtD
Ketorolac—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	9.11e-05	0.000167	CcSEcCtD
Ketorolac—Hypotension—Doxorubicin—peripheral nervous system neoplasm	9.06e-05	0.000166	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	9.05e-05	0.000166	CcSEcCtD
Ketorolac—Fatigue—Epirubicin—peripheral nervous system neoplasm	9.04e-05	0.000166	CcSEcCtD
Ketorolac—Constipation—Epirubicin—peripheral nervous system neoplasm	8.97e-05	0.000164	CcSEcCtD
Ketorolac—Pain—Epirubicin—peripheral nervous system neoplasm	8.97e-05	0.000164	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	8.84e-05	0.000162	CcSEcCtD
Ketorolac—Insomnia—Doxorubicin—peripheral nervous system neoplasm	8.77e-05	0.000161	CcSEcCtD
Ketorolac—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	8.71e-05	0.00016	CcSEcCtD
Ketorolac—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	8.65e-05	0.000159	CcSEcCtD
Ketorolac—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	8.64e-05	0.000158	CcSEcCtD
Ketorolac—Somnolence—Doxorubicin—peripheral nervous system neoplasm	8.62e-05	0.000158	CcSEcCtD
Ketorolac—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	8.57e-05	0.000157	CcSEcCtD
Ketorolac—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	8.54e-05	0.000157	CcSEcCtD
Ketorolac—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	8.43e-05	0.000155	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	8.38e-05	0.000154	CcSEcCtD
Ketorolac—Fatigue—Doxorubicin—peripheral nervous system neoplasm	8.36e-05	0.000153	CcSEcCtD
Ketorolac—Urticaria—Epirubicin—peripheral nervous system neoplasm	8.33e-05	0.000153	CcSEcCtD
Ketorolac—Constipation—Doxorubicin—peripheral nervous system neoplasm	8.3e-05	0.000152	CcSEcCtD
Ketorolac—Pain—Doxorubicin—peripheral nervous system neoplasm	8.3e-05	0.000152	CcSEcCtD
Ketorolac—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	8.29e-05	0.000152	CcSEcCtD
Ketorolac—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	8.29e-05	0.000152	CcSEcCtD
Ketorolac—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	7.99e-05	0.000147	CcSEcCtD
Ketorolac—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	7.93e-05	0.000146	CcSEcCtD
Ketorolac—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	7.72e-05	0.000142	CcSEcCtD
Ketorolac—Urticaria—Doxorubicin—peripheral nervous system neoplasm	7.71e-05	0.000141	CcSEcCtD
Ketorolac—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	7.67e-05	0.000141	CcSEcCtD
Ketorolac—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	7.67e-05	0.000141	CcSEcCtD
Ketorolac—Asthenia—Epirubicin—peripheral nervous system neoplasm	7.52e-05	0.000138	CcSEcCtD
Ketorolac—Pruritus—Epirubicin—peripheral nervous system neoplasm	7.42e-05	0.000136	CcSEcCtD
Ketorolac—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	7.17e-05	0.000132	CcSEcCtD
Ketorolac—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	7.15e-05	0.000131	CcSEcCtD
Ketorolac—Asthenia—Doxorubicin—peripheral nervous system neoplasm	6.96e-05	0.000128	CcSEcCtD
Ketorolac—Dizziness—Epirubicin—peripheral nervous system neoplasm	6.93e-05	0.000127	CcSEcCtD
Ketorolac—Pruritus—Doxorubicin—peripheral nervous system neoplasm	6.86e-05	0.000126	CcSEcCtD
Ketorolac—Vomiting—Epirubicin—peripheral nervous system neoplasm	6.67e-05	0.000122	CcSEcCtD
Ketorolac—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	6.64e-05	0.000122	CcSEcCtD
Ketorolac—Rash—Epirubicin—peripheral nervous system neoplasm	6.61e-05	0.000121	CcSEcCtD
Ketorolac—Dermatitis—Epirubicin—peripheral nervous system neoplasm	6.6e-05	0.000121	CcSEcCtD
Ketorolac—Headache—Epirubicin—peripheral nervous system neoplasm	6.57e-05	0.00012	CcSEcCtD
Ketorolac—Dizziness—Doxorubicin—peripheral nervous system neoplasm	6.42e-05	0.000118	CcSEcCtD
Ketorolac—Nausea—Epirubicin—peripheral nervous system neoplasm	6.23e-05	0.000114	CcSEcCtD
Ketorolac—Vomiting—Doxorubicin—peripheral nervous system neoplasm	6.17e-05	0.000113	CcSEcCtD
Ketorolac—Rash—Doxorubicin—peripheral nervous system neoplasm	6.12e-05	0.000112	CcSEcCtD
Ketorolac—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	6.11e-05	0.000112	CcSEcCtD
Ketorolac—Headache—Doxorubicin—peripheral nervous system neoplasm	6.08e-05	0.000111	CcSEcCtD
Ketorolac—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.76e-05	0.000106	CcSEcCtD
